Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
Acute demyelinating events following vaccines - a case centered analysis.
Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Fingolimod and cardiac risk: latest findings and clinical implications.
Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit
Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin.
Clinical and epidemiological profiles of non-traumatic myelopathies.
A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis.
Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms).
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Positive association of vitamin d receptor gene variations with multiple sclerosis in South East Iranian population.
Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8-B4 microglia.
[Protocol for neurophysiological studies of the pelvic floor to appraise anorectal dysfunction in patients with multiple sclerosis].
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Cellulose/soy protein composite-based nerve guidance conduits with designed microstructure for peripheral nerve regeneration.
Clinical perspectives of TRAIL: insights into central nervous system disorders.
Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.
Deficiency of NF-kappaB c-Rel Accelerates the Development of Autoimmune Diabetes in Non-Obese Diabetic Mice.
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Inhibin-a immunoreactivity in nervous system lesions.
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.
Transdermal immunotherapy: Past, present and future.
Pages
« first
‹ previous
…
676
677
678
679
680
681
682
683
684
…
next ›
last »